I was reviewing cannabis brand data recently— a chart that compares price against quantity sold. In a traditional industry, it would resemble a downward-sloping demand curve.

But cannabis is not a traditional industry.

Instead of finding a simple graph, I found a hodge-podge of plot points, almost randomized, with little rhyme or reason: young brands, old brands, successful brands, struggling brands—all thrown into the messy mix.

A federal judge is setting new deadlines for U.S. Customs and Border Protection (CBP) to respond to an ongoing lawsuit seeking specific policy language on the agency’s approach to cannabis at the U.S-Canada border. For the past few years, Canadian cannabis industry employees and investors have been turned away at the border—and, in some cases, barred from the U.S. outright.

Customs officials seized nearly five tons of cannabis last week from a truck that was attempting to cross into the U.S. at the Peace Bridge Port of Entry on New York’s border with Canada, federal law enforcement officers announced on Monday. The seizure is the third large pot bust this month at the border crossing that has seen an uptick in smuggling via commercial vehicles since travel restrictions called in response to the COVID-19 pandemic were put in place this spring.

A 36-year-old Cambridge man is charged with possession and transportation of illegal drugs, after border officers seized about 190 kilograms of cannabis at the Ambassador Bridge Friday.

According to a U.S. Customs and Border Protection (CBP) media release issued on Monday, the Cambridge man was driving a municipal waste hauler and was referred for inspection around 4 a.m. on Friday.  

During the inspection — which included an x-ray and physical examination — CBP officers discovered several "odd shapes" in the back of the vehicle, ultimately finding 15 "large trash bags" of cannabis.

CBD & THC INFUSED DRINKS TO BENEFIT FROM “THE LIPSTICK EFFECT” AS CONSUMERS SEEK OUT SMALL LUXURIES DURING COVID-19 LOCKDOWN AND BEYOND

Global cannabis sales are expected to surge 38% to $20.4 billion this year despite the coronavirus-induced recession, according to new research from Arcview Group. 

The market research company released the 8th edition of its The State of Legal Cannabis Markets report this week, which also predicted sales will climb to a whopping $46.8 billion in 2025. 

Other highlights from the report include insights and statistics on both new and established legal cannabis markets in the U.S.

It’s hard to say where we are in the COVID-19 pandemic right now, as infections and deaths continue to rise. But there have been movements in the cannabis industry that are changing the way the industry operates amid the pandemic that may stay post-pandemic.

Being allowed to operate as an “essential” business in the U.S. — which had a few bumps in the road between including both medical with recreational as essential businesses in states such as Colorado (that state quickly changed and added recreational) and Massachusetts — was one positive result that gave the industry some needed respect.

Sales have been strong, and delivery options were expanded as well.

Though men tend to smoke greater amounts and more frequently than women, women tend be more sensitive to marijuana consumption.

We know women and men react differently to cannabis. The endocannabinoid system — the set of receptors that bond with consumed marijuana — interacts directly and indirectly with estrogen in a women’s body. A 2009 study, published in the European Journal of Pharmacology, found the amount of CB1 receptors in a woman’s body fluctuates depending on estrogen levels, meaning women experience more intense highs when their estrogen levels peak.

Reliva had been trying to raise venture-capital money at a $40 million valuation before taking that amount in Aurora stock for acquisition

The courtship between Aurora Cannabis Inc. and Reliva began, as many such romances do, at a gathering of industry bigwigs and bankers.